164 results on '"Costs and Cost Analysis"'
Search Results
2. Physician and informal care use explained by the Pediatric Quality of Life Inventory (PedsQL) in children with suspected genetic disorders
3. The path to sustainable cardiac surgery in Rwanda: analysis of costs for consumables used during cardiac surgery for a non-governmental organization
4. A scoping review of costing methodologies used to assess interventions for underserved pregnant people and new parents
5. Medication reviews by emergency department pharmacists in patients hospitalised for an adverse drug event: a cost study
6. Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments
7. Medical costs of Swedish nursing home residents at the end of life: a retrospective observational registry study
8. 3D printing vs traditional workflow for the fabrication of mandibular implant overdentures: study protocol for a mixed-methods cross-over RCT
9. Outcomes and costs with the introduction of robotic-assisted thoracic surgery in public hospitals
10. Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions
11. Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective
12. Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis
13. Comorbidity, Criminality, and Costs of Patients Treated for Gambling Disorder in Denmark
14. The Costs of Operating a Student-run Free Clinic
15. Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
16. Coiling embolization strategy for medium-to-giant-sized intracranial aneurysms treated with pipeline embolization device: a propensity score-weighted study
17. Cost associated with diverting ostomy after rectal cancer surgery: a transnational analysis
18. Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study
19. Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
20. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
21. Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
22. Lifetime direct healthcare costs of treating colorectal cancer: a systematic review
23. Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England
24. Cost effectiveness of melanoma in situ resection and repair by dermatology compared to non-dermatology specialties at a single institution
25. Achieving Lower LDL-C Levels After a Recent Myocardial Infarction Might Be Associated with Lower Healthcare Resource Use and Costs in Spain
26. The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials
27. Quality of cost evaluations of physician continuous professional development: Systematic review of reporting and methods
28. Comparison of outcome and costs of robotic and laparoscopic right hemicolectomies
29. The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark
30. In-patient care trends in peripheral artery disease in the German healthcare system over the past decade
31. What are the economic dimensions of occupational health and how should they be measured? A qualitative study
32. Profile of judicialization in access to antineoplastic drugs and their costs: a cross-sectional, descriptive study based on a set of all lawsuits filed between 2016 and 2018 in a state in the Northeast Region of Brazil
33. Pragmatic considerations and approaches for measuring staff time as an implementation cost in health systems and clinics: key issues and applied examples
34. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
35. Extending analytic methods for economic evaluation in implementation science
36. Human resource needs and costs for HIV pre-exposure prophylaxis provision in nurse-led primary care in Eswatini and opportunities for task sharing
37. The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
38. The impact of the COVID-19 pandemic on patients’ experiences obtaining a tuberculosis diagnosis in Peru: a mixed-methods study
39. Cost savings of a primary care program for individuals recently released from prison: a propensity-matched study
40. The economic burden of infertility treatment and distribution of expenditures overtime in France: a self-controlled pre-post study
41. Ressourcenverbrauch der strukturierten Transition junger Menschen mit seltener Erkrankung aus der Pädiatrie in die Erwachsenenmedizin: Aufwand und Kostenanalyse aus dem Projekt TRANSLATE-NAMSE
42. Retrospective cost-analysis of the EndoPredict test in patients with primary breast cancer in a German breast center
43. Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study
44. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
45. Costs of distributing HIV self-testing kits in Eswatini through community and workplace models
46. Intravaginal electrical stimulation associated with pelvic floor muscle training for women with stress urinary incontinence: study protocol for a randomized controlled trial with economic evaluation
47. Measuring cost and affordability of current vs. healthy diets in Argentina: an application of linear programming and the INFORMAS protocol
48. Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database
49. Hospitalization budget impact during the COVID-19 pandemic in Spain
50. Cost analysis of informal care: estimates from a national cross-sectional survey in Sweden
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.